VEGF165	0	7	B-Gene_or_gene_product
mediates	8	16	O
formation	17	26	O
of	27	29	O
complexes	30	39	O
containing	40	50	O
VEGFR	51	56	B-Gene_or_gene_product
-	56	57	I-Gene_or_gene_product
2	57	58	I-Gene_or_gene_product
and	59	62	O
neuropilin	63	73	B-Gene_or_gene_product
-	73	74	I-Gene_or_gene_product
1	74	75	I-Gene_or_gene_product
that	76	80	O
enhance	81	88	O
VEGF165	89	96	B-Gene_or_gene_product
-	96	97	O
receptor	97	105	O
binding	106	113	O
.	113	114	O

Co	116	118	O
-	118	119	O
expression	119	129	O
of	130	132	O
NRP1	133	137	B-Gene_or_gene_product
and	138	141	O
(	142	143	O
VEGFR	143	148	B-Gene_or_gene_product
-	148	149	I-Gene_or_gene_product
2	149	150	I-Gene_or_gene_product
)	150	151	O
KDR	152	155	B-Gene_or_gene_product
on	156	158	O
the	159	162	O
surface	163	170	O
of	171	173	O
endothelial	174	185	B-Cell
cells	186	191	I-Cell
(	192	193	O
EC	193	195	B-Cell
)	195	196	O
enhances	197	205	O
VEGF165	206	213	B-Gene_or_gene_product
binding	214	221	O
to	222	224	O
KDR	225	228	B-Gene_or_gene_product
and	229	232	O
EC	233	235	B-Cell
chemotaxis	236	246	O
in	247	249	O
response	250	258	O
to	259	261	O
VEGF165	262	269	B-Gene_or_gene_product
.	269	270	O

Overexpression	271	285	O
of	286	288	O
NRP1	289	293	B-Gene_or_gene_product
by	294	296	O
prostate	297	305	B-Cell
tumor	306	311	I-Cell
cells	312	317	I-Cell
in	318	320	O
vivo	321	325	O
results	326	333	O
in	334	336	O
increased	337	346	O
tumor	347	352	B-Pathological_formation
angiogenesis	353	365	O
and	366	369	O
growth	370	376	O
.	376	377	O

We	378	380	O
investigated	381	393	O
the	394	397	O
molecular	398	407	O
mechanisms	408	418	O
underlying	419	429	O
NRP1	430	434	B-Gene_or_gene_product
-	434	435	O
mediated	435	443	O
angiogenesis	444	456	O
by	457	459	O
analyzing	460	469	O
the	470	473	O
association	474	485	O
of	486	488	O
NRP1	489	493	B-Gene_or_gene_product
and	494	497	O
KDR	498	501	B-Gene_or_gene_product
.	501	502	O

An	503	505	O
intracellular	506	519	O
complex	520	527	O
containing	528	538	O
NRP1	539	543	B-Gene_or_gene_product
and	544	547	O
KDR	548	551	B-Gene_or_gene_product
was	552	555	O
immunoprecipitated	556	574	O
from	575	579	O
EC	580	582	B-Cell
by	583	585	O
anti	586	590	O
-	590	591	O
NRP1	591	595	B-Gene_or_gene_product
antibodies	596	606	O
only	607	611	O
in	612	614	O
the	615	618	O
presence	619	627	O
of	628	630	O
VEGF165	631	638	B-Gene_or_gene_product
.	638	639	O

In	640	642	O
contrast	643	651	O
,	651	652	O
VEGF121	653	660	B-Gene_or_gene_product
,	660	661	O
which	662	667	O
does	668	672	O
not	673	676	O
bind	677	681	O
to	682	684	O
NRP1	685	689	B-Gene_or_gene_product
,	689	690	O
did	691	694	O
not	695	698	O
support	699	706	O
complex	707	714	O
formation	715	724	O
.	724	725	O

Complexes	726	735	O
containing	736	746	O
VEGF165	747	754	B-Gene_or_gene_product
,	754	755	O
NRP1	756	760	B-Gene_or_gene_product
,	760	761	O
and	762	765	O
KDR	766	769	B-Gene_or_gene_product
were	770	774	O
also	775	779	O
formed	780	786	O
in	787	789	O
an	790	792	O
intercellular	793	806	O
fashion	807	814	O
by	815	817	O
co	818	820	O
-	820	821	O
culture	821	828	O
of	829	831	O
EC	832	834	B-Cell
expressing	835	845	O
KDR	846	849	B-Gene_or_gene_product
only	850	854	O
,	854	855	O
with	856	860	O
cells	861	866	B-Cell
expressing	867	877	O
NRP1	878	882	B-Gene_or_gene_product
only	883	887	O
,	887	888	O
for	889	892	O
example	893	900	O
,	900	901	O
breast	902	908	B-Cell
carcinoma	909	918	I-Cell
cells	919	924	I-Cell
.	924	925	O

VEGF165	926	933	B-Gene_or_gene_product
also	934	938	O
mediated	939	947	O
the	948	951	O
binding	952	959	O
of	960	962	O
a	963	964	O
soluble	965	972	O
NRP1	973	977	B-Gene_or_gene_product
dimer	978	983	O
to	984	986	O
cells	987	992	B-Cell
expressing	993	1003	O
KDR	1004	1007	B-Gene_or_gene_product
only	1008	1012	O
,	1012	1013	O
confirming	1014	1024	O
the	1025	1028	O
formation	1029	1038	O
of	1039	1041	O
such	1042	1046	O
complexes	1047	1056	O
.	1056	1057	O

Furthermore	1058	1069	O
,	1069	1070	O
the	1071	1074	O
formation	1075	1084	O
of	1085	1087	O
complexes	1088	1097	O
containing	1098	1108	O
KDR	1109	1112	B-Gene_or_gene_product
and	1113	1116	O
NRP1	1117	1121	B-Gene_or_gene_product
markedly	1122	1130	O
increased	1131	1140	O
125I	1141	1145	B-Gene_or_gene_product
-	1145	1146	I-Gene_or_gene_product
VEGF165	1146	1153	I-Gene_or_gene_product
binding	1154	1161	O
to	1162	1164	O
KDR	1165	1168	B-Gene_or_gene_product
.	1168	1169	O

Our	1170	1173	O
results	1174	1181	O
suggest	1182	1189	O
that	1190	1194	O
formation	1195	1204	O
of	1205	1207	O
a	1208	1209	O
ternary	1210	1217	O
complex	1218	1225	O
of	1226	1228	O
VEGF165	1229	1236	B-Gene_or_gene_product
,	1236	1237	O
KDR	1238	1241	B-Gene_or_gene_product
,	1241	1242	O
and	1243	1246	O
NRP1	1247	1251	B-Gene_or_gene_product
potentiates	1252	1263	O
VEGF165	1264	1271	B-Gene_or_gene_product
binding	1272	1279	O
to	1280	1282	O
KDR	1283	1286	B-Gene_or_gene_product
.	1286	1287	O

These	1288	1293	O
complexes	1294	1303	O
are	1304	1307	O
formed	1308	1314	O
on	1315	1317	O
the	1318	1321	O
surface	1322	1329	O
of	1330	1332	O
EC	1333	1335	B-Cell
and	1336	1339	O
in	1340	1342	O
a	1343	1344	O
juxtacrine	1345	1355	O
manner	1356	1362	O
via	1363	1366	O
association	1367	1378	O
of	1379	1381	O
tumor	1382	1387	B-Cell
cell	1388	1392	I-Cell
NRP1	1393	1397	B-Gene_or_gene_product
and	1398	1401	O
EC	1402	1404	B-Cell
KDR	1405	1408	B-Gene_or_gene_product
.	1408	1409	O

